Phase 4 Asthma Trial, Recruiting NCT03615742 Sponsor: University of British Columbia Condition: Asthma
Back to Asthma

Phase 4 Asthma Trial, Recruiting

NCT03615742
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 19 and 49 years old
  • You have been diagnosed with asthma by a doctor, and this will be confirmed during a screening visit through a physical exam, a breathing test (spirometry), a specific airway sensitivity test (methacholine challenge), and questionnaires

Who may not be able to join:

  • You smoke or have smoked (even a small amount over your lifetime), or currently use vaping or vaporizing devices
  • You regularly take antihistamines, anti-inflammatory painkillers (like ibuprofen), steroids, or other long-term asthma/allergy control medications
  • You are currently pregnant or breastfeeding
  • Your airway sensitivity test result (methacholine PC20) is above a certain level, meaning your airways are not sensitive enough to qualify (confirm with trial site)
  • You have a significant heart condition or irregular heartbeat
  • Your body mass index (BMI) — a measure of body weight relative to height — is above 35
  • You are currently taking part in another research study that could affect this one
  • You have used steroid medications, either inhaled or taken by mouth, in the past 6 months
  • You have other significant health conditions identified by the study doctor, or the doctor has other concerns about your participation (confirm with trial site)
  • You have surgery planned before the study is expected to finish

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Chris Carlsten, MD, University of British Columbia

Phone: 6048755132

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
1 December 2018
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Change in DNA methylation, mRNA and protein expression attributable to diesel exhaust and inhaled corticosteroid

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov